Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acitretin Plus Pioglitazone in Psoriasis
NCT00395941Phase 2Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Dec 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in psoriasis comparing Acitretin + Pioglitazone with Acitretin + Placebo (2 arms). Primary endpoint: Change in Psoriasis Area and Severity Index Score at 12 weeks. Started Dec 2006; status: completed.
02
Drugs
pioglitazone
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT00395941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00395941.